The activation of TLR3, which has been evaluated in anti-viral responses induced after CVB3 or CVB4 infection in the mouse model of viral myocarditis, exerts a protective anti-viral function in these mice, reducing viral load in heart tissue by promoting type I and type II IFN production [22, 23]. The gene discussed is SGCG; the disease is viral myocarditis.